Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection

NCT00761020 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

31

Enrollment

FED

Sponsor class

Conditions

Malaria

Interventions

DRUG: Mefloquine
OTHER: Control

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]